Hanmi Science (008930) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.011x

Based on the latest financial reports, Hanmi Science (008930) has a cash flow conversion efficiency ratio of 0.011x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.12 Billion ≈ $6.86 Million USD) by net assets (₩959.19 Billion ≈ $650.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hanmi Science (008930) liquidity interval to measure how many days the company can operate on defensive assets alone.

Hanmi Science - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Hanmi Science's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hanmi Science Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hanmi Science ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
HIAG Immobilien Holding AG
SW:HIAG
0.015x
Shanghai Environment Group Co Ltd
SHG:601200
0.037x
RHI Magnesita NV
VI:RHIM
0.134x
Zillow Group Inc
NASDAQ:ZG
0.045x
Harrow Health Inc
NASDAQ:HROW
-0.317x
Jiangsu Wujiang Rural Coml Bk
SHG:603323
-0.276x
J & J Snack Foods Corp
NASDAQ:JJSF
0.018x
Jiangsu Rongtai Industry Co. Ltd.
SHG:605133
0.029x

Annual Cash Flow Conversion Efficiency for Hanmi Science (2000–2025)

The table below shows the annual cash flow conversion efficiency of Hanmi Science from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Hanmi Science (008930) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩959.19 Billion
≈ $650.03 Million
₩47.66 Billion
≈ $32.30 Million
0.050x -49.79%
2024-12-31 ₩838.70 Billion
≈ $568.38 Million
₩82.99 Billion
≈ $56.24 Million
0.099x +121.62%
2023-12-31 ₩787.47 Billion
≈ $533.66 Million
₩35.16 Billion
≈ $23.83 Million
0.045x +242.35%
2022-12-31 ₩724.75 Billion
≈ $491.15 Million
₩9.45 Billion
≈ $6.41 Million
0.013x -34.24%
2021-12-31 ₩690.29 Billion
≈ $467.80 Million
₩13.69 Billion
≈ $9.28 Million
0.020x -5.45%
2020-12-31 ₩658.73 Billion
≈ $446.41 Million
₩13.82 Billion
≈ $9.36 Million
0.021x +3.99%
2019-12-31 ₩645.69 Billion
≈ $437.57 Million
₩13.02 Billion
≈ $8.83 Million
0.020x +387.66%
2018-12-31 ₩653.09 Billion
≈ $442.59 Million
₩2.70 Billion
≈ $1.83 Million
0.004x +108.17%
2017-12-31 ₩665.15 Billion
≈ $450.76 Million
₩-33.68 Billion
≈ $-22.83 Million
-0.051x -142.85%
2016-12-31 ₩647.56 Billion
≈ $438.84 Million
₩76.52 Billion
≈ $51.86 Million
0.118x +47.12%
2015-12-31 ₩584.25 Billion
≈ $395.94 Million
₩46.93 Billion
≈ $31.80 Million
0.080x +539.61%
2014-12-31 ₩417.71 Billion
≈ $283.08 Million
₩5.25 Billion
≈ $3.55 Million
0.013x +2287.90%
2013-12-31 ₩409.07 Billion
≈ $277.22 Million
₩-234.79 Million
≈ $-159.11K
-0.001x -100.95%
2010-12-31 ₩604.83 Billion
≈ $409.88 Million
₩36.49 Billion
≈ $24.73 Million
0.060x -55.95%
2009-12-31 ₩444.88 Billion
≈ $301.49 Million
₩60.93 Billion
≈ $41.29 Million
0.137x +31.54%
2008-12-31 ₩393.00 Billion
≈ $266.33 Million
₩40.92 Billion
≈ $27.73 Million
0.104x -48.66%
2006-12-31 ₩291.16 Billion
≈ $197.32 Million
₩59.05 Billion
≈ $40.02 Million
0.203x -4.83%
2005-12-31 ₩219.66 Billion
≈ $148.86 Million
₩46.81 Billion
≈ $31.72 Million
0.213x +53.31%
2004-12-31 ₩181.81 Billion
≈ $123.21 Million
₩25.27 Billion
≈ $17.13 Million
0.139x -4.75%
2003-12-31 ₩155.62 Billion
≈ $105.46 Million
₩22.71 Billion
≈ $15.39 Million
0.146x -34.08%
2002-12-31 ₩146.43 Billion
≈ $99.23 Million
₩32.42 Billion
≈ $21.97 Million
0.221x -22.75%
2001-12-31 ₩131.69 Billion
≈ $89.25 Million
₩37.74 Billion
≈ $25.58 Million
0.287x +39.40%
2000-12-31 ₩90.93 Billion
≈ $61.62 Million
₩18.69 Billion
≈ $12.67 Million
0.206x --

About Hanmi Science

KO:008930 Korea Medical Distribution
Market Cap
$1.42 Billion
₩2.09 Trillion KRW
Market Cap Rank
#7626 Global
#204 in Korea
Share Price
₩30900.00
Change (1 day)
+1.81%
52-Week Range
₩28450.00 - ₩51900.00
All Time High
₩138933.39
About

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more